Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Fish and Richardson
Johnson and Johnson
Argus Health
McKinsey
Baxter
Harvard Business School
Julphar
Merck
Accenture

Generated: January 22, 2018

DrugPatentWatch Database Preview

HALOPERIDOL Drug Profile

« Back to Dashboard

When do Haloperidol patents expire, and when can generic versions of Haloperidol launch?

Haloperidol is a drug marketed by Alpharma, Morton Grove, Pharm Assoc, SCS, Silarx, Teva, Teva Pharms, Abraxis Pharm, Akorn, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Marsam Pharms Llc, Mylan Labs Ltd, Sagent Pharms, Sandoz Inc, Smith And Nephew, Solopak, Teva Pharms Usa, Watson Labs, West-ward Pharms Int, Anda Repository, Cycle Pharms Ltd, Duramed Pharms Barr, Lederle, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sandoz, Vintage, Zydus Pharms Usa, Hospira, and Actavis Mid Atlantic. and is included in one hundred and six NDAs.

The generic ingredient in HALOPERIDOL is haloperidol decanoate. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Drug patent expirations by year for HALOPERIDOL
Pharmacology for HALOPERIDOL

US Patents and Regulatory Information for HALOPERIDOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Royce Labs HALOPERIDOL haloperidol TABLET;ORAL 071724-001 Dec 24, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs HALOPERIDOL haloperidol TABLET;ORAL 071375-001 Jun 3, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr HALOPERIDOL haloperidol TABLET;ORAL 071216-001 Dec 4, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anda Repository HALOPERIDOL haloperidol TABLET;ORAL 071212-001 Jan 7, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Scs HALOPERIDOL haloperidol TABLET;ORAL 070724-001 Jun 10, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075440-001 Feb 28, 2000 AO RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle HALOPERIDOL haloperidol TABLET;ORAL 072729-001 Sep 19, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gland Pharma Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 205241-002 May 12, 2017 AO RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm HALOPERIDOL haloperidol TABLET;ORAL 071071-001 Nov 3, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr HALOPERIDOL haloperidol TABLET;ORAL 071220-001 Jul 7, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Healthtrust
McKinsey
Citi
Dow
AstraZeneca
Harvard Business School
Accenture
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot